Treatment for Prediabetic State

Albert Einstein College of Medicine of Yeshiva University, Bronx, NY
Prediabetic State+1 More
Eligible conditions
Prediabetic State

Study Summary

This study is evaluating whether a specific eating schedule may help improve health in humans.

See full description

Eligible Conditions

  • Prediabetic State
  • PreDiabetes

Treatment Effectiveness

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 4 secondary outcomes in patients with Prediabetic State. Measurement will happen over the course of 1 week.

1 week
Autophagy level
5 weeks
Body Composition
Energy expenditure
Glucose tolerance
Insulin sensitivity

Trial Safety

Trial Design

1 Treatment Groups


This trial requires 25 total participants across 1 different treatment groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

ControlNo treatment in the control group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 weeks
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 5 weeks for reporting.

Closest Location

Albert Einstein College of Medicine of Yeshiva University - Bronx, NY

Eligibility Criteria

This trial is for male patients aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
● Men, age 30-70 years. In this preliminary study, recruitment is limited to men because data from the relevant animal studies showed marked sexual dimorphism, with more pronounced metabolic effects in males. Future studies will include both males and females.
IFG or IGT based on 75g OGTT (fasting plasma glucose 100 -125 mg/dl and/or 2-hr glucose between 140 - 199 mg/dl); Or diabetes (FPG > 126 mg/dl or 2 hr glucose > 200 mg/dl) not on treatment and with HbA1c < 6.8% can also be enrolled.
BMI 25-35 kg/m2

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Prediabetic State by sharing your contact details with the study coordinator.